Chris Moxon on How BCG Sees the Future of the DSO Market
What will separate the next generation of winning dental support organizations (DSOs) from the roll-up models of the past? In this episode of The Dental Economist Show, host CRO Mike Huffaker of Planet DDS speaks with Chris Moxon, managing director and partner at Boston Consulting Group (BCG), about the future of the DSO market, consolidation, and the operational foundations required for sustainable growth.
Moxon shares BCG’s data-led perspective on why dentistry remains a compelling market: resilient underlying demand, a significant number of patients still outside the care system, and growing recognition of the connection between oral and overall health. He explains how preventative care, salivary diagnostics, and better patient communication can improve treatment acceptance while creating better outcomes.
The conversation also explores the realities of DSO consolidation. Chris explains why dental is unlikely to consolidate like pharmacy, why de novo growth depends on more than capital and real estate, and why strategic acquisitions need a clear clinical and operational rationale. He also discusses lender-controlled platforms, specialty growth, clinician incentives, and why the doctors with the greatest clinical autonomy may be working inside the best-run DSOs.
Why the DSO Market Is Entering a New Phase of Growth
About The Dental Economist Show
Don’t miss insightful conversations with industry experts on the latest trends and top strategies to grow your DSO or dental group. Tune in to The Dental Economist Show each week as we meet at the intersection of profit and purpose.
Listen to the full podcast:
